Other Species / Isoforms
  CDT1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T7-p
_MEQRRVtDFFARRR
Upstream
Downstream
1 1
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
Kinase, in vitro:
  • AurB (human)
CDT1 (human) _MEQRRVtDFFARRR T7-p
CDT1 (mouse) _MAQSRVTDFYACRR T7
K24-ub
PPRIAPPkLACRtPs
0 6
CDT1 (human) PPRIAPPkLACRtPs K24-ub
CDT1 (mouse) GLTTPRAkSICLtPs K23-ub
T29-p
PPkLACRtPsPARPA
Upstream
Downstream
3 12
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
  • transcription, inhibited
Kinase, in vitro:
  • CDK2 (human)
Putative in vivo kinases:
  • JNK1 (human)
Treatment
  • JNK_inhibitor_I
  • sorbitol
  • SP600125
CDT1 (human) PPkLACRtPsPARPA T29-p
CDT1 (mouse) RAkSICLtPsPGGLV T28-p
S31-p
kLACRtPsPARPALR
Upstream
2 11
Kinase, in vitro:
  • CDK2 (human)
CDT1 (human) kLACRtPsPARPALR S31-p
CDT1 (mouse) kSICLtPsPGGLVAP S30-p
S42-p
PALRAPAsAtsGSRK
0 1
CDT1 (human) PALRAPAsAtsGSRK S42-p
CDT1 (mouse) GGLVAPAFTRSSSRK F39
T44-p
LRAPAsAtsGSRKRA
0 1
CDT1 (human) LRAPAsAtsGSRKRA T44-p
CDT1 (mouse) LVAPAFTRSSSRKRA R41
S45-p
RAPAsAtsGSRKRAR
0 1
CDT1 (human) RAPAsAtsGSRKRAR S45-p
CDT1 (mouse) VAPAFTRSSSRKRAR S42
S73-p
ARRRLRLsVDEVSSP
0 4
CDT1 (human) ARRRLRLsVDEVSSP S73-p
CDT1 (mouse) PSSPAEPSPPADPSP S89
T82-p
DEVSSPStPEAPDIP
0 3
CDT1 (human) DEVSSPStPEAPDIP T82-p
CDT1 (mouse) SPPADPSPPADPGSP P96
S93-p
PDIPACPsPGQKIKK
Upstream
1 7
Treatment
  • ischemia
  • JNK_inhibitor_I
  • sorbitol
  • SP600125
CDT1 (human) PDIPACPsPGQKIKK S93-p
CDT1 (mouse) PGSPVCPSPVKRTKS S107
T102-p
GQKIKKStPAAGQPP
Upstream
Downstream
1 1
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
Kinase, in vitro:
  • AurB (human)
CDT1 (human) GQKIKKStPAAGQPP T102-p
CDT1 (mouse) VKRTKSTTVYVGQQP T116
T112-p
AGQPPHLtSAQDQDT
0 1
CDT1 (human) AGQPPHLtSAQDQDT T112-p
CDT1 (mouse) GQQPGKIPSEDSVSE P127
K141-ub
GARVRALkAsAQDAG
0 2
CDT1 (human) GARVRALkAsAQDAG K141-ub
CDT1 (mouse) GAQARALRARVQENA R153
K141-sm
GARVRALkAsAQDAG
0 1
CDT1 (human) GARVRALkAsAQDAG K141-sm
CDT1 (mouse) GAQARALRARVQENA R153
S143-p
RVRALkAsAQDAGES
Upstream
Downstream
1 1
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
Kinase, in vitro:
  • AurB (human)
CDT1 (human) RVRALkAsAQDAGES S143-p
CDT1 (mouse) QARALRARVQENAVE R155
T152-p
QDAGESCtPEAEGRP
0 2
CDT1 (human) QDAGESCtPEAEGRP T152-p
CDT1 (mouse) ENAVEPSTPDAKVPT T165
K166-ub
PEEPCGEkAPAYQRF
0 2
CDT1 (human) PEEPCGEkAPAYQRF K166-ub
CDT1 (mouse) TEQPCVEKAPAYQRF K179
K218-ub
SETPTFAkVQRGVQD
0 1
CDT1 (human) SETPTFAkVQRGVQD K218-ub
CDT1 (mouse) SETVTFAKVKQGVQE K231
K240-ub
ECNVGQIkTVYPASY
0 3
CDT1 (human) ECNVGQIkTVYPASY K240-ub
CDT1 (mouse) ERNVGQIKTVYPTSY K253
K259-ub
ERSVPTFkDGTRRSD
0 2
CDT1 (human) ERSVPTFkDGTRRSD K259-ub
CDT1 (mouse) ECNVPTFKDSIKRSD K272
K259-sm
ERSVPTFkDGTRRSD
0 1
CDT1 (human) ERSVPTFkDGTRRSD K259-sm
CDT1 (mouse) ECNVPTFKDSIKRSD K272
K301-ub
RRQIFSQkLVEHVkE
0 2
CDT1 (human) RRQIFSQkLVEHVkE K301-ub
CDT1 (mouse) RRQVFRQNLVERVKE N313
K307-ub
QkLVEHVkEHHkAFL
0 2
CDT1 (human) QkLVEHVkEHHkAFL K307-ub
CDT1 (mouse) QNLVERVKEQHKVFL K319
K311-ub
EHVkEHHkAFLASLs
0 1
CDT1 (human) EHVkEHHkAFLASLs K311-ub
CDT1 (mouse) ERVKEQHKVFLASLN K323
S318-p
kAFLASLsPAMVVPE
Upstream
1 11
Treatment
  • JNK_inhibitor_I
  • sorbitol
  • SP600125
CDT1 (human) kAFLASLsPAMVVPE S318-p
CDT1 (mouse) KVFLASLNPPMAVPD N330
K356-ub
PQPPATEkLtTAQEV
0 3
CDT1 (human) PQPPATEkLtTAQEV K356-ub
CDT1 (mouse) PQPPVTEKLTTAQEV K368
T358-p
PPATEkLtTAQEVLA
Upstream
Downstream
1 1
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
Kinase, in vitro:
  • AurB (human)
CDT1 (human) PPATEkLtTAQEVLA T358-p
CDT1 (mouse) PPVTEKLTTAQEVLA T370
S372-p
ARARNLIsPRMEkAL
1 5
CDT1 (human) ARARNLIsPRMEkAL S372-p
CDT1 (mouse) ARARSLMTPKMEKAL T384
K377-ub
LIsPRMEkALsQLAL
0 3
CDT1 (human) LIsPRMEkALsQLAL K377-ub
CDT1 (mouse) LMTPKMEKALsNLAL K389
K377-sm
LIsPRMEkALsQLAL
0 1
CDT1 (human) LIsPRMEkALsQLAL K377-sm
CDT1 (mouse) LMTPKMEKALsNLAL K389
S380-p
PRMEkALsQLALRSA
0 8
CDT1 (human) PRMEkALsQLALRSA S380-p
CDT1 (mouse) PKMEKALsNLALRSA S392-p
S390-p
ALRSAAPssPGsPrP
0 1
CDT1 (human) ALRSAAPssPGsPrP S390-p
CDT1 (mouse) ALRSAEPGsPGtSTP G402
S391-p
LRSAAPssPGsPrPA
Upstream
Downstream
2 6
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • protein stabilization
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • JNK1 (human)
  • P38A (human)
Treatment
  • JNK_inhibitor_I
  • nocodazole
  • SB203580
  • sorbitol
  • SP600125
  • UV
CDT1 (human) LRSAAPssPGsPrPA S391-p
CDT1 (mouse) LRSAEPGsPGtSTPP S403-p
S394-p
AAPssPGsPrPALPA
Upstream
2 10
Treatment
  • JNK_inhibitor_I
  • sorbitol
  • SP600125
CDT1 (human) AAPssPGsPrPALPA S394-p
CDT1 (mouse) AEPGsPGtSTPPLPA T406-p
R396-m1
PssPGsPrPALPAtP
0 1
CDT1 (human) PssPGsPrPALPAtP R396-m1
CDT1 (mouse) PGsPGtSTPPLPAtP T408
T402-p
PrPALPAtPPAtPPA
Upstream
Downstream
2 8
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • protein stabilization
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • JNK1 (human)
  • P38A (human)
Treatment
  • nocodazole
  • SB203580
  • sorbitol
  • UV
CDT1 (human) PrPALPAtPPAtPPA T402-p
CDT1 (mouse) STPPLPAtPPATPPA T414-p
T406-p
LPAtPPAtPPAAsPs
Upstream
Downstream
2 1
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • protein stabilization
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • JNK1 (human)
  • P38A (human)
Treatment
  • nocodazole
  • SB203580
  • sorbitol
  • UV
CDT1 (human) LPAtPPAtPPAAsPs T406-p
CDT1 (mouse) LPAtPPATPPAASPS T418
S411-p
PAtPPAAsPsALkGV
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • protein stabilization
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • JNK1 (human)
  • P38A (human)
Treatment
  • nocodazole
  • SB203580
  • sorbitol
  • UV
CDT1 (human) PAtPPAAsPsALkGV S411-p
CDT1 (mouse) PATPPAASPSALKGV S423
S413-p
tPPAAsPsALkGVSQ
0 1
CDT1 (human) tPPAAsPsALkGVSQ S413-p
CDT1 (mouse) TPPAASPSALKGVSQ S425
K416-ub
AAsPsALkGVSQDLL
0 2
CDT1 (human) AAsPsALkGVSQDLL K416-ub
CDT1 (mouse) AASPSALKGVSQALL K428
K429-ub
LLERIRAkEAQkQLA
0 1
CDT1 (human) LLERIRAkEAQkQLA K429-ub
CDT1 (mouse) LLERIRAKEVQKQLA K441
K433-ub
IRAkEAQkQLAQMTR
0 3
CDT1 (human) IRAkEAQkQLAQMTR K433-ub
CDT1 (mouse) IRAKEVQKQLARMTR K445
K433-sm
IRAkEAQkQLAQMTR
0 1
CDT1 (human) IRAkEAQkQLAQMTR K433-sm
CDT1 (mouse) IRAKEVQKQLARMTR K445
K470-ub
SVFVSERkPALSMEV
0 1
CDT1 (human) SVFVSERkPALSMEV K470-ub
CDT1 (mouse) NVFVSERKPALTMEV K482
S491-p
GSCCTIMsPGEMEKH
Upstream
Downstream
1 2
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • protein stabilization
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • JNK1 (human)
  • P38A (human)
Treatment
  • nocodazole
  • SB203580
  • sorbitol
  • UV
CDT1 (human) GSCCTIMsPGEMEKH S491-p
CDT1 (mouse) DSCQTALSPGEMEKH S503
K522-ub
IRTDTYVkLDkAADL
0 2
CDT1 (human) IRTDTYVkLDkAADL K522-ub
CDT1 (mouse) IRTDTYVKLDKAVDL K534
K525-ub
DTYVkLDkAADLAHI
0 2
CDT1 (human) DTYVkLDkAADLAHI K525-ub
CDT1 (mouse) DTYVKLDKAVDLAGL K537
T533-p
AADLAHItARLAHQT
0 1
CDT1 (human) AADLAHItARLAHQT T533-p
CDT1 (mouse) AVDLAGLTARLAHHV T545